General Information of Drug (ID: DME384W)

Drug Name
AdPEDR Drug Info
Indication
Disease Entry ICD 11 Status REF
Exudative age-related macular degeneration 9B78.3Z Phase 2 [1]
Cross-matching ID
PubChem CID
11557063
TTD Drug ID
DME384W

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PEDF gene therapy DM4CY2G Macular degeneration 9B78.3 Phase 1 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Pigment epithelium-derived factor (SERPINF1) TTR59S1 PEDF_HUMAN Inhibitor [1]

References

1 Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration. Expert Opin Emerg Drugs. 2005 Feb;10(1):119-35.
2 Adenovector pigment epithelium-derived factor (AdPEDF) delivery for wet age-related macular degeneration. Retina. 2005 Dec;25(8 Suppl):S48-S49.